NDC80 and breast cancer: In addition, it has been also reported that using small molecule, which specifically disrupts the Hec1–Nek2 (NIMA-related kinase 2) mitotic pathway, retarded tumour growth in a nude mouse model bearing xenografts derived from human breast cancer cell line [9].